Harrison CN, Kiladjian J-J, Al-Ali H-K, Gisslinger H, Knoops L, Waltzman RJ, Copley-Merriman K. Health-related quality of life and symptoms in myelofibrosis patients treated with ruxolitinib versus best available therapy. Presented at the European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes; May 2012.